Limaca Medical Developed Novel Precision GI™ Endoscopic Biopsy Device
Limaca Medical has developed the novel Precision GI™ Endoscopic Ultrasound (EUS) Biopsy Device, revolutionising the diagnostic process for pancreatic cancer and other critical gastrointestinal (GI) malignancies.
Precision GI™, an automated medical device, designed to greatly enhance the efficiency and effectiveness of GI cancer diagnosis. Precision GI™ stands as a pioneering solution that promises reliable and accurate results, ultimately improving the diagnosis of GI cancers.
Precision GI™ features a cutting-edge motorised, automated rotational cutting needle. This unique technology ensures the successful, safe, and precise acquisition of high-quality tissue samples. By eliminating the variability associated with manual operation.
Precision GI™ is engineered to enhance the efficiency and effectiveness of GI cancer diagnosis by consistently producing superior-quality and more substantial diagnostically relevant biopsy samples.
Unlike existing devices that rely on manual hand operation, Precision GI™ features a cutting-edge motorised, automated rotational cutting needle.
The FDA clearance of Precision GI™, coupled with FDA breakthrough device designation, marks a significant advancement in the realm of endoscopic biopsies. This breakthrough innovation promises to enhance the overall biopsy experience for both endoscopists and patients, aiming for greater speed, efficiency, and consistently reliable results.